{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:50:15Z","timestamp":1760205015361,"version":"3.37.3"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"name":"South-Central University for Nationalities","award":["XTZ15014","CZP 18008"],"award-info":[{"award-number":["XTZ15014","CZP 18008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31640034"],"award-info":[{"award-number":["31640034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2019,6,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The formation of hyperphosphorylated tau and the production of \u03b2-amyloid are thought to be critical steps contributing to the pathological mechanisms in Alzheimer\u2019s disease (AD). However, there has been a long-lasting debate over their importance in the onset of AD. Recent studies have demonstrated that axonopathy is considered as an early neuropathological change of AD. However, the exact relationship between the development of axonopathy and the classic neuropathological changes such as senile plaques (SPs) and neurofibrillary tangles (NFTs) is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The aim of this study was to investigate whether the formation of SPs and NFTs is associated with the development of axonal leakage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method and Results:<\/jats:title><jats:p>Here we show that the formation and development of axonal leakage - a novel axonopathy is an age-dependent process, accompanied by swellings of axons and varicosities and associated with chronic oxidative stress induced by thiamine deficient (TD) diet in Kunming mice. In an APP\/PS1 transgenic mouse model of AD, axonal leakage appears at 3 months, becomes more obvious at 6 months and severe, beyond 1 year. We also show that slight axonal leakage is related to the formation of hyperphosphorylated tau, but not plaques, and that only severe axonal leakage accompanied by the extensive swollen axons and varicosities, and overproduction of \u03b2-amyloid leads to the formation of SPs and hyperphosphorylated tau.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>These data provide an explanation of the common origin and development of SPs and NFTs, and suggest that axonal leakage might be a key event in the development of the neuropathological processes in AD.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1566524019666190405174908","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T10:30:04Z","timestamp":1554805804000},"page":"183-195","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models"],"prefix":"10.2174","volume":"19","author":[{"given":"Ge","family":"Gao","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxia","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xing","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiapei","family":"Dai","sequence":"additional","affiliation":[{"name":"Wuhan Institute for Neuroscience and Neuroengineering, South-Central University for Nationalities, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1088\/0954-898X_13_3_305","volume":"13","author":"Wouterlood F.G.","year":"2002","unstructured":"Wouterlood FG, Vinkenoog M, van den Oever M. Tracing tools to resolve neural circuits.","journal-title":"Network"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12264-017-0193-3","volume":"33","author":"Wang Q.H.","year":"2017","unstructured":"Wang QH, Wang X, Bu XL. Comorbidity burden of dementia: A hospital-based retrospective study from 2003 to 2012 in seven cities in china.","journal-title":"Neurosci Bull"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00005072-199311000-00009","volume":"52","author":"Masliah E.","year":"1993","unstructured":"Masliah E, Mallory M, Deerinck T. Re-evaluation of the structural organization of neuritic plaques in Alzheimer\u2019s disease.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0002-9440(10)65533-2","volume":"155","author":"Spittaels K.","year":"1999","unstructured":"Spittaels K, Van den Haute C, Van Dorpe J. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.","journal-title":"Am J Pathol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"41340","DOI":"10.1074\/jbc.M006219200","volume":"275","author":"Spittaels K.","year":"2000","unstructured":"Spittaels K, Van den Haute C, Van Dorpe J. Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.","journal-title":"J Biol Chem"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0006-8993(02)03152-9","volume":"948","author":"Dai J.","year":"2002","unstructured":"Dai J, Buijs RM, Kamphorst W. Impaired axonal transport of cortical neurons in Alzheimer\u2019s disease is associated with neuropathological changes.","journal-title":"Brain Res"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/NMM:2:2:131","volume":"2","author":"Higuchi M.","year":"2002","unstructured":"Higuchi M, Lee VM, Trojanowski JQ. Tau and axonopathy in neurodegenerative disorders.","journal-title":"Neuromolecular Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cne.10186","volume":"446","author":"Bian F.","year":"2002","unstructured":"Bian F, Nath R, Sobocinski G. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.","journal-title":"J Comp Neurol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"Stokin G.B.","year":"2005","unstructured":"Stokin GB, Lillo C, Falzone TL. Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease.","journal-title":"Science"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.nbd.2005.12.013","volume":"22","author":"Yoon S.Y.","year":"2006","unstructured":"Yoon SY, Choi JE, Yoon JH. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.","journal-title":"Neurobiol Dis"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1471-4159.2006.03955.x","volume":"98","author":"G\u00f6tz J.","year":"2006","unstructured":"G\u00f6tz J, Ittner LM, Kins S. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer\u2019s disease?","journal-title":"J Neurochem"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00401-006-0041-4","volume":"111","author":"Wirths O.","year":"2006","unstructured":"Wirths O, Weis J, Szczygielski J. Axonopathy in an APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease.","journal-title":"Acta Neuropathol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1471-4159.2007.04603.x","volume":"102","author":"Yang Y.","year":"2007","unstructured":"Yang Y, Yang XF, Wang YP. Inhibition of protein phosphatases induces transport deficits and axonopathy.","journal-title":"J Neurochem"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuroimage.2007.01.046","volume":"35","author":"Smith K.D.","year":"2007","unstructured":"Smith KD, Kallhoff V, Zheng H. axonal transport rates decrease in a mouse model of Alzheimer\u2019s disease.","journal-title":"Neuroimage"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1523\/JNEUROSCI.4272-06.2007","volume":"27","author":"Lazarov O.","year":"2007","unstructured":"Lazarov O, Morfini GA, Pigino G. Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer\u2019s disease-linked mutant presenilin 1.","journal-title":"J Neurosci"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/s00259-007-0707-8","volume":"35","author":"Minoshima S.","year":"2008","unstructured":"Minoshima S, Cross D. imaging of axonal transport using MRI: aging and Alzheimer\u2019s disease.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/brain\/awn312","volume":"132","author":"Adalbert R.","year":"2008","unstructured":"Adalbert R, Nogradi A, Babetto E. Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies.","journal-title":"Brain"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.brainresbull.2009.08.004","volume":"80","author":"Vickers J.C.","year":"2009","unstructured":"Vickers JC, King AE, Woodhouse A. Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system.","journal-title":"Brain Res Bull"},{"key":"ref=19","volume":"7","author":"Zhang Q.","year":"2012","unstructured":"Zhang Q, Gao T, Luo Y. Transient focal cerebral ischemia\/reperfusion induces early and chronic axonal changes in rats: its importance for the risk of Alzheimer\u2019s disease.","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JAD-121762","volume":"34","author":"Zhou Y.","year":"2013","unstructured":"Zhou Y, Luo Y, Dai J. Axonal and dendritic changes are associated with diabetic encephalopathy in rats: An important risk factor for Alzheimer\u2019s disease.","journal-title":"J Alzheimers Dis"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.1073\/pnas.1603119113","volume":"113","author":"Dennissen F.J.","year":"2016","unstructured":"Dennissen FJ, Anglada-Huguet M, Sydow A. Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau \u0394K280.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1534\/genetics.116.186932","volume":"204","author":"Seehusen F.","year":"2016","unstructured":"Seehusen F, Kiel K, Jottini S. Axonopathy in the central nervous system is the hallmark of mice with a novel intragenic null mutation of dystonin.","journal-title":"Genetics"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.celrep.2017.09.027","volume":"21","author":"Gilley J.","year":"2017","unstructured":"Gilley J, Ribchester RR, Coleman MP. Sarm1 deletion, but Not Wld(S), confers lifelong rescue in a mouse model of severe axonopathy.","journal-title":"Cell Rep"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3233\/JAD-180497","volume":"65","author":"Wang S.","year":"2018","unstructured":"Wang S, He B, Hang W. Berberine alleviates tau hyperphosphorylation and axonopathy-associated with diabetic encephalopathy restoring PI3K\/Akt\/GSK3\u03b2 pathway.","journal-title":"J Alzheimers Dis"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12264-011-1736-7","volume":"27","author":"Xiao A.W.","year":"2011","unstructured":"Xiao AW, He J, Wang Q. The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer\u2019s disease.","journal-title":"Neurosci Bull"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","volume":"9","author":"Krstic D.","year":"2013","unstructured":"Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease.","journal-title":"Nat Rev Neurol"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"Jankowsky J.L.","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide : evidence for augmentation of a 42-specific gamma secretase.","journal-title":"Hum Mol Genet"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jnen\/62.2.195","volume":"62","author":"Ke Z.J.","year":"2003","unstructured":"Ke ZJ, DeGiorgio LA, Volpe BT. Reversal of thiamine deficiency-induced neurodegeneration.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=29","unstructured":"Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, Third ed. People\u2019s Medical Publishing House, Beijing. 2005."},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-9861(19981012)400:1<87::AID-CNE6>3.0.CO;2-P","volume":"400","author":"Dai J.","year":"1998","unstructured":"Dai J, Swaab DF, Van der Vliet J. Postmortem tracing reveals the organization of hypothalamic projections of the suprachiasmatic nucleus in the human brain.","journal-title":"J Comp Neurol"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0270(98)00039-9","volume":"81","author":"Erisir A.","year":"1998","unstructured":"Erisir A, Aoki C. A method of combining biocytin tract-tracing with avidin-biotin-peroxidase complex immunocytochemistry for pre-embedding electron microscopic labeling in neonatal tissue.","journal-title":"J Neurosci Methods"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/35050103","volume":"408","author":"Chen G.","year":"2000","unstructured":"Chen G, Chen KS, Knox J. A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer\u2019s disease.","journal-title":"Nature"},{"key":"ref=33","first-page":"327","volume":"12002","author":"Wouterlood F.G.","year":"","unstructured":"Wouterlood FG, Vinkenoog M, van den Oever M. Tracing tools to resolve neural circuits.","journal-title":"Network"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/00005072-199909000-00005","volume":"58","author":"Calingasan N.Y.","year":"1999","unstructured":"Calingasan NY, Chun WJ, Park LC. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency.","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.neuroscience.2006.10.008","volume":"144","author":"Wang X.","year":"2007","unstructured":"Wang X, Wang B, Fan Z. Thiamine deficiency induces endoplasmic reticulum stress in neurons.","journal-title":"Neuroscience"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1749-6632.1982.tb31213.x","volume":"378","author":"Gibson G.","year":"1982","unstructured":"Gibson G, Barclay L, Blass J. The role of the cholinergic system in thiamin deficiency.","journal-title":"Ann N Y Acad Sci"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuint.2003.09.008","volume":"45","author":"Ke Z.J.","year":"2004","unstructured":"Ke ZJ, Gibson GE. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism.","journal-title":"Neurochem Int"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/ajpath.2007.060378","volume":"170","author":"Yamamoto M.","year":"2007","unstructured":"Yamamoto M, Kiyota T, Horiba M. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.","journal-title":"Am J Pathol"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.18388\/abp.2007_3252","volume":"54","author":"Chornyy S.","year":"2007","unstructured":"Chornyy S, Parkhomenko J, Chorna N. Thiamine deficiency caused by thiamine antagonists triggers upregulation of apoptosis inducing factor gene expression and leads to caspase 3-mediated apoptosis in neuronally differentiated rat PC-12 cells.","journal-title":"Acta Biochim Pol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.12.013","volume":"30","author":"Karuppagounder S.S.","year":"2009","unstructured":"Karuppagounder SS, Xu H, Shi Q. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer\u2019s mouse model.","journal-title":"Neurobiol Aging"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0306-9877(93)90051-Q","volume":"40","author":"Perry G.","year":"1993","unstructured":"Perry G. Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.","journal-title":"Med Hypotheses"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2003.09.009","volume":"25","author":"Sch\u00f6nheit B.","year":"2004","unstructured":"Sch\u00f6nheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology.","journal-title":"Neurobiol Aging"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)61206-0","volume":"167","author":"Trojanowski J.Q.","year":"2005","unstructured":"Trojanowski JQ, Lee VM-Y. The Alzheimer\u2019s brain binding out what\u2019s broken tells us how to fix it.","journal-title":"Am J Pathol"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1212\/WNL.42.7.1315","volume":"42","author":"Arai H.","year":"1992","unstructured":"Arai H, Schmidt ML, Lee VM. Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson\u2019s disease.","journal-title":"Neurology"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1002\/j.1460-2075.1990.tb07563.x","volume":"9","author":"Steiner B.","year":"1990","unstructured":"Steiner B, Mandelkow EM, Biernat J. Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2 (+)-calmodulin dependent kinase and relationship with tau hosphorylation in Alzheimer tangles.","journal-title":"EMBO J"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj3090041","volume":"309","author":"Fleming L.M.","year":"1995","unstructured":"Fleming LM, Johnson GV. Modulation of the phosphorylation state of tau : the roles of calcium and cyclic AMP.","journal-title":"Biochem J"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T21:13:16Z","timestamp":1607202796000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171372\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6,10]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524019666190405174908","relation":{},"ISSN":["1566-5240"],"issn-type":[{"type":"print","value":"1566-5240"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}